NSE filing, NSE: NIVABUPA. Summary written from the filing by ALFA Finder's alert engine.
Niva Bupa Health Insurance Company Ltd: key numbers
- Share price
- ₹75.00
- Market cap
- ₹13,880 Cr
- Revenue (annual)
- ₹6,695 Cr
- Net profit (annual)
- ₹130.8 Cr
- P/E (TTM)
- 38.5×Sector 19.4×
- Promoter holding
- 55.29%-0.01% QoQ
- FII holding
- 12.95%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Niva Bupa Health Insurance Company Ltd
All →Niva Bupa Health Insurance Company Board Meeting Outcome
Niva Bupa Health Insurance Company's Board approved amendments and the consolidation of its PIT policies. The updated policy integrates UPSI fair disclosure and leak inquiry procedures into a single framework.
Niva Bupa Health Insurance Company Investor Presentation: Key Takeaways
H1 FY27 GWP ₹4,634 Cr (+33.4% y-o-y, 1/n basis); PAT ₹273.4 Cr, more than doubled; CISR improved to 99.5% from 103.1%; retail health share 11.0%.
Niva Bupa Health Insurance Company Q2 FY27 Results: Net Profit ₹135.6 Cr, Up 124.1% YoY
Niva Bupa Health Insurance Company Ltd reported revenue from operations of ₹2,572 Cr (+25.5% YoY) and net profit of ₹135.6 Cr (+124.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹135.6 Cr · +124.1% YoY
Niva Bupa Health Insurance Company Employee Stock Options
Niva Bupa allotted 9,89,450 equity shares to employees on exercise of ESOP options under its 2020 and 2024 schemes. Paid-up capital rose to Rs. 18,50,63,41,530.
Niva Bupa Health Insurance Company Board Meeting Date
Niva Bupa will hold a board meeting on November 4, 2026 to consider unaudited results for the quarter and half-year ended September 30, 2026. The trading window stays closed until November 6, 2026.
Niva Bupa Health Insurance Company Management Change
Niva Bupa Health Insurance Company Limited announced the sad demise of Mr. Roger William John Davis, a Non-Executive Non-Independent Director, effective October 17, 2026.
Other other announcement announcements
All →M. K. Sons Fine Jewels Other Announcement
M. K. Sons Fine Jewels filed its pre-listing shareholding pattern as of 3 November 2026. It is a routine Regulation 31 disclosure with no transaction.
Ajwa Projects Other Announcement
Ajwa Projects filed its quarterly shareholding pattern as of November 4, 2026. It is a routine Regulation 31 disclosure of pre-listing holdings.
Amwill Health Care Other Announcement
Amwill Health Care committed ₹3 Crore to Nippon India Credit Opportunities AIF Scheme II. The investment, funded from internal accruals, is drawn down in tranches.
- Value
- ₹3.00 Cr
Kenvi Jewels Other Announcement
Kenvi Jewels informs BSE that its RTA, KFIN Technologies, will relocate its corporate office from 1 December 2026, with the registered office unchanged. The RTA appointment terms are unaffected, and shareholders should send correspondence to the new address.
AWL Agri Business Other Announcement
AWL Agri Business filed its quarterly shareholding pattern for the quarter ended 30 September 2026. The filing is routine regulatory disclosure with no transaction.
Sashwat Technocrats Other Announcement
Sashwat Technocrats informed BSE the escrow payment mechanism is not applicable to it. This is a routine compliance clarification with no financial impact.